Skip to content
value.today

Reshape Medical, Inc.

Total raised
$76 M
6 rounds on record
Latest round
$38 M
Aug 2015
First round on record
May 2012
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Reshape Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2015$38 MNo. 6$10 to $50 million

Reshape Medical, Inc.: Raise no. 6, Aug 2015

Investors in this round

10 investors had bought by the notice of Sep 2, 2015: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$38 M of $38 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • Richard Thompson · Executive Officer, Director
  • Casey Tansey · Director
  • David Milne · Director
  • Eric Milledge · Director
  • Jeani Delagardelle · Director
  • John Lehmann, M.D. · Director
  • Kenneth Charhut · Director
  • Michael Mashaal · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed Sep 2, 2015. Read the notice at the SEC.

equitySEC
Mar 2015$9 MNo. 5$2 to $10 million

Reshape Medical, Inc.: Raise no. 5, Mar 2015

Investors in this round

7 investors had bought by the notice of Mar 19, 2015: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • Richard Thompson · Executive Officer, Director
  • Casey Tansey · Director
  • David Milne · Director
  • Jeani Delagardelle · Director
  • John Lehmann, M.D. · Director
  • Kenneth Charhut · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed Mar 19, 2015. Read the notice at the SEC.

debt, optionsSEC
Jan 2015$7 MNo. 4$2 to $10 million

Reshape Medical, Inc.: Raise no. 4, Jan 2015

Investors in this round

7 investors had bought by the notice of Feb 4, 2015: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • Richard Thompson · Executive Officer, Director
  • Casey Tansey · Director
  • David Milne · Director
  • Jeani Delagardelle · Director
  • John Lehmann, M.D. · Director
  • Kenneth Charhut · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed Feb 4, 2015. Read the notice at the SEC.

debt, optionsSEC
Jun 2014$5 MNo. 3$2 to $10 million

Reshape Medical, Inc.: Raise no. 3, Jun 2014

Investors in this round

7 investors had bought by the notice of Dec 11, 2014: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • Richard Thompson · Executive Officer, Director
  • Casey Tansey · Director
  • David Milne · Director
  • Jeani Delagardelle · Director
  • John Lehmann, M.D. · Director
  • Kenneth Charhut · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce Feuchter, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Dec 11, 2014. Read the notice at the SEC.

debt, optionsSEC
Oct 2012$16 MNo. 2$10 to $50 million

Reshape Medical, Inc.: Raise no. 2, Oct 2012

Investors in this round

7 investors had bought by the notice of Oct 19, 2012: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $21 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • Richard Thompson · Executive Officer, Director
  • Casey Tansey · Director
  • David Milne · Director
  • George Wallace · Director
  • Jeani Delagardelle · Director
  • Kenneth Charhut · Director
  • Robert Grant · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed Oct 19, 2012. Read the notice at the SEC.

equitySEC
May 2012$2 MNo. 1Under $2 million

Reshape Medical, Inc.: Raise no. 1, May 2012

Investors in this round

7 investors had bought by the notice of Jun 6, 2012: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Feuchter · Executive Officer
  • Richard Thompson · Executive Officer, Director
  • Casey Tansey · Director
  • David Milne · Director
  • George Wallace · Director
  • Jeani Delagardelle · Director
  • Kent Charhut · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce Feuchter, Secretary. Source: SEC Form D, newest notice filed Jun 6, 2012. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Reshape Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2015).

    SEC Form D · Sep 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2015

That is all the official record says: Reshape Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Reshape Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Reshape Medical, Inc.
NameRoleNamed in
Bruce FeuchterExecutive officerSep 2015
Richard ThompsonExecutive officerSep 2015
Casey TanseyDirectorSep 2015
David MilneDirectorSep 2015
Eric MilledgeDirectorSep 2015
Jeani DelagardelleDirectorSep 2015
John Lehmann, M.D.DirectorSep 2015
Kenneth CharhutDirectorSep 2015
Michael MashaalDirectorSep 2015
Richard ThompsonDirectorSep 2015
James AdoxDirectorJul 2014
George WallaceDirectorOct 2012
Robert GrantDirectorOct 2012
Kent CharhutDirectorJun 2012